Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prothena Corp (NQ: PRTA )

34.89 +2.31 (+7.09%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,007,689
Open 32.46
Bid (Size) 34.95 (8)
Ask (Size) 54.00 (1)
Prev. Close 32.58
Today's Range 31.96 - 34.94
52wk Range 28.51 - 79.65
Shares Outstanding 45,047,449
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this  
Via Benzinga
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
Biotech companies are edging closer to finding the answers behind Alzheimer's disease. 
Via Investor's Business Daily

Performance

YTD
-34.79%
-34.79%
1 Month
-4.31%
-4.31%
3 Month
-33.95%
-33.95%
6 Month
-51.92%
-51.92%
1 Year
-44.18%
-44.18%

More News

Read More
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Prothena Reports Third Quarter 2023 Financial Results and Business Highlights
From Prothena Corporation plc
Via Business Wire
Earnings Preview For Prothena Corp
Via Benzinga
Expert Ratings for Prothena Corp
Via Benzinga
Expert Ratings for Prothena Corp
Via Benzinga
JMP Securities Maintains Outperform Rating for Prothena Corp: Here's What You Need To Know
Via Benzinga
Prothena to Report Third Quarter 2023 Financial Results on November 2
From Prothena Corporation plc
Via Business Wire
Biogen Pulls Prothena Into A Steep Dive On Mixed Results For Alzheimer's Treatment
Via Investor's Business Daily
Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For August 3, 2023
Via Benzinga
Prothena Corp's Earnings Outlook
Via Benzinga
Expert Ratings for Prothena Corp
Via Benzinga
8 Analysts Have This to Say About Prothena Corp
Via Benzinga
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Prothena to Participate in Upcoming Healthcare Conferences
From Prothena Corporation plc
Via Business Wire
Prothena Reports Second Quarter 2023 Financial Results and Business Highlights
From Prothena Corporation plc
Via Business Wire
Prothena to Report Second Quarter 2023 Financial Results on August 3
From Prothena Corporation plc
Via Business Wire
Prothena Presents New Research in the Treatment of Alzheimer’s Disease at Alzheimer’s Association International Conference® 2023 (AAIC®)
From Prothena Corporation plc
Via Business Wire
Prothena to Present New Data from Alzheimer’s Disease Programs at Alzheimer’s Association International Conference® 2023 (AAIC®)
From Prothena Corporation plc
Via Business Wire
Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody
From Prothena Corporation plc
Via Business Wire
Prothena Announces Phase 3 VITAL Clinical Trial Results Published in Blood Showing Survival Benefit in Patients with Mayo Stage IV AL Amyloidosis Treated with Birtamimab
From Prothena Corporation plc
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.